Patients as a direct source of information on adverse drug reactions.
- 8 October 1988
- Vol. 297 (6653) , 891-893
- https://doi.org/10.1136/bmj.297.6653.891
Abstract
To determine whether patients should participate directly in detecting adverse reactions to drugs their ability to provide written reports of symptoms experienced during treatment with amoxycillin or trimethoprim-sulphamethoxazole was investigated. When compared with telephone interviews forms on which patients reported events were reliable (the observed agreement with the same statements posed during telephone calls was 85%, kappa = 0.56) and valid (sensitivity = 54%, specificity = 94%). Patients were also supplied with forms that invited them to report adverse reactions, and their perceptions were compared with those of a panel of experts, who were informed of all clinical events that had been reported during the detailed telephone interviews. Patients were more conservative than the experts in attributing clinical events to drug treatment. The extent of agreement varied and was notably poor for skin and bowel complaints (kappa = 0.13 in each case). The performance of event report forms and reaction report forms as instruments of detection was compared in a hypothetical situation in which the experts' views represented the "truth" about adverse reactions to a new drug. Event reporting had a higher sensitivity than reaction reporting (42% v 24%) but a lower specificity (58% v 98%). National centres monitoring adverse drug reactions should probably resist pressure to accept reports of reactions directly from the public, but a system based on large scale reporting of events might be valuable in aiding the early detection of symptomatic reactions to new drugs.This publication has 11 references indexed in Scilit:
- Patient‐Initiated Postmarketing Surveillance: A Validation StudyThe Journal of Clinical Pharmacology, 1987
- Detecting Adverse Drug Reactions in Postmarketing Surveillance: Interview ValidityDrug Information Journal, 1987
- Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up.BMJ, 1985
- The computerized on-line Medicaid pharmaceutical analysis and surveillance system: A new resource for postmarketing drug surveillanceClinical Pharmacology & Therapeutics, 1985
- Methodologic Issues in Pharmacy-Based Post-Marketing SurveillanceDrug Information Journal, 1985
- Postmarketing drug surveillance by record linkage in Tayside.Journal of Epidemiology and Community Health, 1984
- Postmarketing Follow‐up at Group Health Cooperative of Puget SoundPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1984
- A methodologic study of post-marketing drug evaluation using a pharmacy-based approachJournal of Chronic Diseases, 1982
- Postmarketing surveillance of adverse drug reactions in general practice. II: Prescription-event monitoring at the University of Southampton.BMJ, 1981
- XXXI. On the sensitivity, specificity, and discrimination of diagnostic testsClinical Pharmacology & Therapeutics, 1975